Work

Enhanced Antitumor Efficacy of 225Ac-NM600 Compared to 177Lu-NM600 in Prostate Cancer Models

Year: 2025

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2025.09.072

Authors: Carolina A. Ferreira, Hemanth K. Potluri, Ahmed A. Tantawy, Christopher F. Massey, Joseph J. Grudzinski, Amanda M. Carston, Nathan B. Clemons, Malick Bio Idrissou, Anna S. Thickens, Zachary T. Rosenkrans, Cynthia Choi, Caroline P. Kerr, Anatoly N. Pinchuk, Ohyun Kwon, Justin J. Jeffery, Bryan P. Bednarz, Zachary S. Morris, Jamey P. Weichert, Douglas G. McNeel, Reinier Hernandez

Institutions: Michigan State University, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences

Awards: UW SPECT/CT Acquisition, G2845059676, Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response, COMBINATION OF TARGETED RADIONUCLIDE THERAPY AND IMMUNOTHERAPY FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER, Targeted radionuclide therapy for tumor immunomodulation and enhancing immunotherapy response, UW Comprehensive Cancer Center Support, Integrated Training For Physician-Scientists

OpenAlex ID: W4416808925

FWCI: 0.567

Cites: 28

Cited by: 1

Related to: 10